Morgan Stanley's Sector Downgrade Piles Pressure on CSG as Stock Nears May Nadir

The Czechoslovak Group (CSG) is watching its stock price erode despite a record €17 billion order book, a dovish analyst consensus, and double-digit sales growth. The disconnect between operational strength and market sentiment has rarely been starker — and a fresh downgrade of the whole European defense sector by Morgan Stanley is making it worse.

The US investment bank cut the sector's rating from Overweight to Equal Weight, citing fading momentum, a lack of near-term catalysts, and potential headwinds from possible ceasefire talks in Ukraine. Within Morgan Stanley's internal ranking of 30 European sectors, defense tumbled from fifth to fourteenth place. The call dragged down CSG alongside Rheinmetall, Dassault Aviation and Hensoldt.

CSG shares fell another 3.63% on Tuesday to €14.24, leaving them barely 4% above the 52-week low of €13.65 struck in May. Since January's peak of €36.05, the stock has shed roughly 60% of its value. The relative strength index now reads 28 — deep in oversold territory — underscoring the intensity of the recent selling pressure.

Strong numbers, little reward

Should investors sell immediately? Or is it worth buying CSG?

The operational picture tells a very different story. In the first quarter of 2026, CSG posted revenue of €1.544 billion, up 13.8% year-on-year. Operating EBIT rose 8.7% to €372 million. The order backlog climbed to €17 billion, 15% higher than at the end of 2025, while the sales pipeline reached €27 billion.

Land systems revenue jumped 83% and ammunition sales rose 22%. Around 64% of turnover came from NATO countries, with another 21% from Ukraine. For the full year, management guides for revenue between €7.4 billion and €7.6 billion and an operating EBIT margin of 24% to 25%. Operating cash flow improved by €476 million in the first quarter alone, despite planned spending on production ramp-up.

Yet investors are no longer asking whether CSG can win orders. The question now is whether it can convert those orders into timely, profitable deliveries. The market is increasingly differentiating between defense companies based on technology profile, geographic exposure and conversion track records — rather than treating the whole sector as a single theme play.

Three sources of uncertainty

Several company-specific headwinds are compounding the sector-wide malaise. A bitter legal dispute with minority shareholder Petr Kratochvíl is spooking institutional investors. Kratochvíl is demanding 35 billion Czech koruna for his stakes in two subsidiaries, while majority owner Michal Strnad has offered only 4 billion. Courts in the Czech Republic and Slovakia are now involved, creating an unpredictable overhang that no analyst model can capture.

A second strategic battle is playing out over a stake in the German-French tank maker KNDS. CSG has signalled its interest, but the owning families are resisting, favouring either an initial public offering in July or an entry by the German state. The prolonged uncertainty is weighing on sentiment.

More positively, CSG has taken steps to secure its supply chain. It now holds roughly 20% of the voting rights in Alzchem Group, a German chemicals company that produces key precursors for ammunition. In June, CSG and a partner began joint production of artillery shells directly inside Ukraine, with a target of ramping capacity to 850,000 units per year by the end of 2026.

CSG at a turning point? This analysis reveals what investors need to know now.

All ten analysts say buy

Despite the stock's descent, not a single analyst covering CSG recommends selling. Every one of the ten analysts rates the shares a buy, with an average price target of approximately €32 — more than double the current level. The market is ignoring those calls entirely.

The next major test comes on August 7, when CSG publishes its half-year report. Management will need to demonstrate that the order conversion is keeping pace with expectations and that the company's internal conflicts — legal, strategic, and governance-related — are not undermining the underlying business. If the selling pressure persists, a break below the May low of €13.65 looks entirely possible.

Ad

CSG Stock: New Analysis - 9 June

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | MORGAN | boerse | 69508383 |